• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌男性和女性患者之间的差异:是性别差异还是性别鸿沟?

Disparities between male and female patients with thyroid cancers: sex difference or gender divide?

作者信息

Machens Andreas, Hauptmann Steffen, Dralle Henning

机构信息

Departments of General, Visceral and Vascular Surgery, Martin Luther University Halle-Wittenberg, Halle, Saale, Germany.

出版信息

Clin Endocrinol (Oxf). 2006 Oct;65(4):500-5. doi: 10.1111/j.1365-2265.2006.02623.x.

DOI:10.1111/j.1365-2265.2006.02623.x
PMID:16984243
Abstract

OBJECTIVE

This investigation was undertaken to quantify histopathological disparities between male and female patients with sporadic and hereditary thyroid cancers, which may reflect a biological 'sex difference' or a behavioural 'gender divide'.

DESIGN

Retrospective cohort analysis (November 1994-January 2006).

PATIENTS

1298 Consecutive surgical patients with sporadic papillary (n = 587), sporadic follicular (n = 232), sporadic medullary (n = 320), and hereditary medullary thyroid cancers (n = 159) from a tertiary referral centre.

MEASUREMENTS

Age at diagnosis of cancer, primary tumour diameter, frequency of extrathyroidal extension, lymph node and distant metastases, and cancer subtypes.

RESULTS

Primary diameters of sporadic tumour entities (papillary, 26.0 vs. 19.3 mm; follicular, 54.9 vs. 35.1 mm; and medullary, 27.9 vs. 20.8 mm), but not hereditary medullary cancers, were significantly (P <or= 0.001) larger in male patients. Likewise, lymph node metastases from sporadic papillary cancers (60%vs. 44%, P < 0.001), the insular subtype in sporadic follicular cancers (22%vs. 8%, P = 0.003), extrathyroidal extension of sporadic medullary cancers (35%vs. 15%, P < 0.001), and distant metastases from sporadic medullary cancers at the most recent operation (29%vs. 15%, P = 0.002) were seen significantly more often with male patients. No significant differences were observed between male and female patients with hereditary medullary cancers, half of which were detected by screening.

CONCLUSIONS

Our data emphasize the need for earlier diagnosis and intervention in male patients to ensure that male sex will cease sometime to constitute an ominous prognostic marker of advanced thyroid cancer.

摘要

目的

开展此项研究以量化散发性和遗传性甲状腺癌男性与女性患者之间的组织病理学差异,这可能反映出生物学上的“性别差异”或行为学上的“性别分化”。

设计

回顾性队列分析(1994年11月至2006年1月)。

患者

来自一家三级转诊中心的1298例连续性手术患者,包括散发性乳头状癌(n = 587)、散发性滤泡状癌(n = 232)、散发性髓样癌(n = 320)和遗传性髓样癌(n = 159)。

测量指标

癌症诊断时的年龄、原发肿瘤直径、甲状腺外侵犯频率、淋巴结及远处转移情况以及癌症亚型。

结果

男性患者散发性肿瘤实体(乳头状癌,26.0对19.3毫米;滤泡状癌,54.9对35.1毫米;髓样癌,27.9对20.8毫米)的原发直径显著更大(P≤0.001),但遗传性髓样癌除外。同样,男性患者散发性乳头状癌的淋巴结转移(60%对44%,P < 0.001)、散发性滤泡状癌岛状亚型的转移(22%对8%,P = 0.003)、散发性髓样癌的甲状腺外侵犯(35%对15%,P < 0.001)以及最近一次手术时散发性髓样癌的远处转移(29%对15%,P = 0.002)更为常见。遗传性髓样癌的男性与女性患者之间未观察到显著差异,其中一半是通过筛查发现的。

结论

我们的数据强调需要对男性患者进行更早的诊断和干预,以确保男性性别不再成为晚期甲状腺癌不良预后的标志。

相似文献

1
Disparities between male and female patients with thyroid cancers: sex difference or gender divide?甲状腺癌男性和女性患者之间的差异:是性别差异还是性别鸿沟?
Clin Endocrinol (Oxf). 2006 Oct;65(4):500-5. doi: 10.1111/j.1365-2265.2006.02623.x.
2
Skip metastases in thyroid cancer leaping the central lymph node compartment.甲状腺癌跳跃中央淋巴结区的跳跃性转移
Arch Surg. 2004 Jan;139(1):43-5. doi: 10.1001/archsurg.139.1.43.
3
Referral bias in thyroid cancer surgery: direction and magnitude.甲状腺癌手术中的转诊偏倚:方向与程度。
Eur J Surg Oncol. 2008 May;34(5):556-62. doi: 10.1016/j.ejso.2007.07.006. Epub 2007 Aug 23.
4
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.对最初接受单侧手术的甲状腺癌患者完成甲状腺切除术。
Clin Endocrinol (Oxf). 2004 Jul;61(1):145-8. doi: 10.1111/j.1365-2265.2004.02065.x.
5
[Management of lymph node metastases in well-differentiated and medullary thyroid cancer: retrospective study on 52 cases].[高分化型及髓样甲状腺癌淋巴结转移的管理:52例回顾性研究]
Ann Ital Chir. 2004 May-Jun;75(3):305-14.
6
Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.甲状腺癌淋巴结转移及远处转移的增强
Cancer. 2003 Aug 15;98(4):712-9. doi: 10.1002/cncr.11581.
7
Prognostic factors of insular versus papillary/follicular thyroid carcinoma.甲状腺岛叶癌与乳头状/滤泡状癌的预后因素
Am Surg. 2004 May;70(5):461-6.
8
Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.甲状腺乳头状癌的乳头状和滤泡状变体:初始表现及对治疗的反应
Otolaryngol Head Neck Surg. 2005 Jun;132(6):840-4. doi: 10.1016/j.otohns.2005.02.002.
9
Prognostic variables and calcitonin in medullary thyroid cancer.甲状腺髓样癌的预后变量与降钙素
Laryngoscope. 2005 Aug;115(8):1445-50. doi: 10.1097/01.mlg.0000168114.90852.a6.
10
Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.甲状腺乳头状癌滤泡状变体的临床表现及手术治疗结果
Jpn J Clin Oncol. 2006 Nov;36(11):688-93. doi: 10.1093/jjco/hyl093. Epub 2006 Sep 25.

引用本文的文献

1
Sex-Based Differences in Medullary Thyroid Cancer Survival: A Matched Analysis of 4602 Patients.甲状腺髓样癌生存的性别差异:4602例患者的匹配分析
Ann Surg Oncol. 2025 Aug 21. doi: 10.1245/s10434-025-18067-1.
2
Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up.甲状腺微小乳头状癌中央区淋巴结转移风险列线图及其术后甲状腺功能随访
Front Endocrinol (Lausanne). 2024 Oct 28;15:1395900. doi: 10.3389/fendo.2024.1395900. eCollection 2024.
3
Predicting factors and clinical outcome of biochemical incomplete response in middle eastern differentiated thyroid carcinoma.
中东地区分化型甲状腺癌生化不完全缓解的预测因素及临床转归。
Endocrine. 2024 Oct;86(1):268-275. doi: 10.1007/s12020-024-03844-x. Epub 2024 May 2.
4
Increased Pituitary Fluorine-18-Fluorodeoxyglucose Uptake in Patients with Differentiated Thyroid Cancer in Hypothyroidism versus under Recombinant Human Thyroid-Stimulating Hormone Stimulation.甲状腺功能减退与重组人促甲状腺激素刺激下分化型甲状腺癌患者垂体氟-18-氟脱氧葡萄糖摄取增加。
Cancers (Basel). 2024 Mar 31;16(7):1382. doi: 10.3390/cancers16071382.
5
Demographic, clinical, and surgical features of patients undergoing thyroidectomy due to thyroid lesions in Southern Iran: A cross-sectional study.伊朗南部因甲状腺病变接受甲状腺切除术患者的人口统计学、临床和手术特征:一项横断面研究。
Health Sci Rep. 2024 Apr 1;7(4):e2012. doi: 10.1002/hsr2.2012. eCollection 2024 Apr.
6
The American Thyroid Association risk stratification and long-term outcomes of differentiated thyroid cancer: a 20-year follow-up of patients in Saudi Arabia.美国甲状腺协会对分化型甲状腺癌的风险分层和长期预后:沙特阿拉伯患者 20 年随访结果。
Front Endocrinol (Lausanne). 2023 Nov 17;14:1256232. doi: 10.3389/fendo.2023.1256232. eCollection 2023.
7
Sexual disparity and the risk of second primary thyroid cancer: a paradox.性别差异与甲状腺第二原发性癌风险:一个悖论。
Gland Surg. 2023 Apr 28;12(4):432-441. doi: 10.21037/gs-22-411. Epub 2023 Mar 28.
8
High RPMB predicts poor disease-free survival of male N1 papillary thyroid cancer after adjuvant radioiodine therapy.高复发/转移风险分层(RPMB)预示着男性N1期乳头状甲状腺癌患者辅助放射性碘治疗后的无病生存期较差。
Heliyon. 2022 Nov 19;8(11):e11783. doi: 10.1016/j.heliyon.2022.e11783. eCollection 2022 Nov.
9
Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study.中国与美国分化型甲状腺癌的临床病理和外科治疗比较:一项多中心基于医院的研究。
Front Public Health. 2022 Sep 28;10:974359. doi: 10.3389/fpubh.2022.974359. eCollection 2022.
10
Extrathyroidal extension and cervical node infiltration are associated with recurrences and shorter recurrence-free survival in differentiated thyroid cancer: a cohort study.甲状腺外扩展和颈部淋巴结浸润与分化型甲状腺癌的复发及较短的无复发生存期相关:一项队列研究。
Thyroid Res. 2022 Jul 26;15(1):13. doi: 10.1186/s13044-022-00131-7.